Cite
HARVARD Citation
Bagley, S. et al. (n.d.). RBTT-05. A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS. Neuro-oncology. p. vi219. [Online].